APO Research

APO RESEARCH · REPORT

Infusion Software

Selected research

Market Outlook & Growth Opportunities

Global Infusion Software Market Outlook and Growth Opportunities 2026

Market perspective

The global Infusion Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Infusion Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Infusion Software market include B. Braun, Inovalon, Brightree, AlayaCare, Ivenix, CitusHealth, EpiSoft, Eitan Medical and ICU Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Infusion Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infusion Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infusion Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Infusion Software market.

Infusion Software Segment by Company

B. Braun

Inovalon

Brightree

AlayaCare

Ivenix

CitusHealth

EpiSoft

Eitan Medical

ICU Medical

Weinfuse

Universal Software Solutions

WellSky

DoseMeRx

MarketBox

Daycenta

Infusion Software Segment by Type

Dose Error Reduction Software (DERS)

Clinical Workflow Software

Others

Infusion Software Segment by Application

Hospital

Clinic

Home

Infusion Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Infusion Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Infusion Software key companies, revenue, market share, and recent developments.

3. To split the Infusion Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Infusion Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Infusion Software significant trends, drivers, influence factors in global and regions.

6. To analyze Infusion Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infusion Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infusion Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infusion Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infusion Software industry.

Chapter 3: Detailed analysis of Infusion Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Infusion Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Infusion Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Infusion Software Industry Trends Table 2. Infusion Software Industry Drivers Table 3. Infusion Software Industry Opportunities and Challenges Table 4. Infusion Software Industry Restraints Table 5. Global Infusion Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Infusion Software Revenue Share by Company (2021-2026) Table 7. Global Infusion Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Infusion Software Key Company Manufacturing Base & Headquarters Table 9. Global Infusion Software Company, Product Type & Application Table 10. Global Infusion Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Infusion Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dose Error Reduction Software (DERS) Table 15. Significant Companies of Clinical Workflow Software Table 16. Significant Companies of Others Table 17. Global Infusion Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Infusion Software Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Infusion Software Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Infusion Software Sales Value Share by Type (2021-2026) Table 21. Global Infusion Software Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Significant Companies of Home Table 25. Global Infusion Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Infusion Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Infusion Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Infusion Software Sales Value Share by Application (2021-2026) Table 29. Global Infusion Software Sales Value Share by Application (2027-2032) Table 30. Global Infusion Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Infusion Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Infusion Software Sales Value Share by Region (2021-2026) Table 33. Global Infusion Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Infusion Software Sales Value Share by Region (2027-2032) Table 35. Global Infusion Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Infusion Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Infusion Software Sales Value Market Share by Country (2021-2026) Table 38. Global Infusion Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Infusion Software Sales Value Market Share by Country (2027-2032) Table 40. B. Braun Company Information Table 41. B. Braun Business Overview Table 42. B. Braun Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. B. Braun Infusion Software Product Portfolio Table 44. B. Braun Recent Development Table 45. Inovalon Company Information Table 46. Inovalon Business Overview Table 47. Inovalon Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Inovalon Infusion Software Product Portfolio Table 49. Inovalon Recent Development Table 50. Brightree Company Information Table 51. Brightree Business Overview Table 52. Brightree Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Brightree Infusion Software Product Portfolio Table 54. Brightree Recent Development Table 55. AlayaCare Company Information Table 56. AlayaCare Business Overview Table 57. AlayaCare Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. AlayaCare Infusion Software Product Portfolio Table 59. AlayaCare Recent Development Table 60. Ivenix Company Information Table 61. Ivenix Business Overview Table 62. Ivenix Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Ivenix Infusion Software Product Portfolio Table 64. Ivenix Recent Development Table 65. CitusHealth Company Information Table 66. CitusHealth Business Overview Table 67. CitusHealth Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. CitusHealth Infusion Software Product Portfolio Table 69. CitusHealth Recent Development Table 70. EpiSoft Company Information Table 71. EpiSoft Business Overview Table 72. EpiSoft Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. EpiSoft Infusion Software Product Portfolio Table 74. EpiSoft Recent Development Table 75. Eitan Medical Company Information Table 76. Eitan Medical Business Overview Table 77. Eitan Medical Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eitan Medical Infusion Software Product Portfolio Table 79. Eitan Medical Recent Development Table 80. ICU Medical Company Information Table 81. ICU Medical Business Overview Table 82. ICU Medical Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. ICU Medical Infusion Software Product Portfolio Table 84. ICU Medical Recent Development Table 85. Weinfuse Company Information Table 86. Weinfuse Business Overview Table 87. Weinfuse Infusion Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Weinfuse Infusion Software Product Portfolio Table 89. Weinfuse Recent Development Table 90. Universal Software Solutions Company Information Table 91. Universal Software Solutions Business Overview Table 92. Universal Software Solutions Infusion Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Universal Software Solutions Infusion Software Product Portfolio Table 94. Universal Software Solutions Recent Development Table 95. WellSky Company Information Table 96. WellSky Business Overview Table 97. WellSky Infusion Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. WellSky Infusion Software Product Portfolio Table 99. WellSky Recent Development Table 100. DoseMeRx Company Information Table 101. DoseMeRx Business Overview Table 102. DoseMeRx Infusion Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. DoseMeRx Infusion Software Product Portfolio Table 104. DoseMeRx Recent Development Table 105. MarketBox Company Information Table 106. MarketBox Business Overview Table 107. MarketBox Infusion Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. MarketBox Infusion Software Product Portfolio Table 109. MarketBox Recent Development Table 110. Daycenta Company Information Table 111. Daycenta Business Overview Table 112. Daycenta Infusion Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Daycenta Infusion Software Product Portfolio Table 114. Daycenta Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Infusion Software Product Image Figure 2. Global Infusion Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infusion Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Infusion Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dose Error Reduction Software (DERS) Image Figure 8. Clinical Workflow Software Image Figure 9. Others Image Figure 10. Global Infusion Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Infusion Software Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Infusion Software Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Home Image Figure 16. Global Infusion Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Infusion Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Infusion Software Sales Value Share by Application (2021-2032) Figure 19. Global Infusion Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Infusion Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Infusion Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Infusion Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Infusion Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Infusion Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Infusion Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Infusion Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Infusion Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Infusion Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Infusion Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Infusion Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Infusion Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Infusion Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Infusion Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Dose Error Reduction Software (DERS)
  • Clinical Workflow Software
  • Others
Applications
  • Hospital
  • Clinic
  • Home
Companies covered
  • B. Braun
  • Inovalon
  • Brightree
  • AlayaCare
  • Ivenix
  • CitusHealth
  • EpiSoft
  • Eitan Medical
  • ICU Medical
  • Weinfuse
  • Universal Software Solutions
  • WellSky
  • DoseMeRx
  • MarketBox
  • Daycenta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Infusion Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Infusion Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Infusion Software Market Dynamics
  1. 2.1 Infusion Software Industry Trends
  2. 2.2 Infusion Software Industry Drivers
  3. 2.3 Infusion Software Industry Opportunities and Challenges
  4. 2.4 Infusion Software Industry Restraints
3 Infusion Software Market by Company
  1. 3.1 Global Infusion Software Company Revenue Ranking in 2025
  2. 3.2 Global Infusion Software Revenue by Company (2021-2026)
  3. 3.3 Global Infusion Software Company Ranking (2024-2026)
  4. 3.4 Global Infusion Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Infusion Software Company Product Type and Application
  6. 3.6 Global Infusion Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Infusion Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Infusion Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Infusion Software Market by Type
  1. 4.1 Infusion Software Type Introduction
  2. 4.1.1 Dose Error Reduction Software (DERS)
  3. 4.1.2 Clinical Workflow Software
  4. 4.1.3 Others
  5. 4.2 Global Infusion Software Sales Value by Type
  6. 4.2.1 Global Infusion Software Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Infusion Software Sales Value by Type (2021-2032)
  8. 4.2.3 Global Infusion Software Sales Value Share by Type (2021-2032)
5 Infusion Software Market by Application
  1. 5.1 Infusion Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home
  5. 5.2 Global Infusion Software Sales Value by Application
  6. 5.2.1 Global Infusion Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Infusion Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Infusion Software Sales Value Share by Application (2021-2032)
6 Infusion Software Regional Value Analysis
  1. 6.1 Global Infusion Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infusion Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Infusion Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Infusion Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Infusion Software Sales Value (2021-2032)
  7. 6.3.2 North America Infusion Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Infusion Software Sales Value (2021-2032)
  10. 6.4.2 Europe Infusion Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Infusion Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Infusion Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Infusion Software Sales Value (2021-2032)
  16. 6.6.2 South America Infusion Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Infusion Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Infusion Software Sales Value Share by Country, 2025 VS 2032
7 Infusion Software Country-level Value Analysis
  1. 7.1 Global Infusion Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Infusion Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Infusion Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Infusion Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Infusion Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Infusion Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Infusion Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Infusion Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Infusion Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Infusion Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Infusion Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Infusion Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Infusion Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Infusion Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Infusion Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Infusion Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Infusion Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Infusion Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Infusion Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Infusion Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Infusion Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Infusion Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Infusion Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Infusion Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Infusion Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Infusion Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Infusion Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Infusion Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Infusion Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Infusion Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Infusion Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Infusion Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Infusion Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Infusion Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Infusion Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Infusion Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Infusion Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Infusion Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Infusion Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Infusion Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Infusion Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Infusion Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Infusion Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Infusion Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Infusion Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Infusion Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Infusion Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Infusion Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Infusion Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Infusion Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Infusion Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Infusion Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Infusion Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Infusion Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Infusion Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Infusion Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Infusion Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Infusion Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Infusion Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Infusion Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Infusion Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Infusion Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Infusion Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Infusion Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Infusion Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Infusion Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Infusion Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Infusion Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Infusion Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Infusion Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Infusion Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Infusion Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Infusion Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Infusion Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Infusion Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Infusion Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Infusion Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Infusion Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Infusion Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Infusion Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Infusion Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Infusion Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Infusion Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Infusion Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Infusion Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Infusion Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Infusion Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Infusion Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 B. Braun
  2. 8.1.1 B. Braun Company Information
  3. 8.1.2 B. Braun Business Overview
  4. 8.1.3 B. Braun Infusion Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 B. Braun Infusion Software Product Portfolio
  6. 8.1.5 B. Braun Recent Developments
  7. 8.2 Inovalon
  8. 8.2.1 Inovalon Company Information
  9. 8.2.2 Inovalon Business Overview
  10. 8.2.3 Inovalon Infusion Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Inovalon Infusion Software Product Portfolio
  12. 8.2.5 Inovalon Recent Developments
  13. 8.3 Brightree
  14. 8.3.1 Brightree Company Information
  15. 8.3.2 Brightree Business Overview
  16. 8.3.3 Brightree Infusion Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Brightree Infusion Software Product Portfolio
  18. 8.3.5 Brightree Recent Developments
  19. 8.4 AlayaCare
  20. 8.4.1 AlayaCare Company Information
  21. 8.4.2 AlayaCare Business Overview
  22. 8.4.3 AlayaCare Infusion Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AlayaCare Infusion Software Product Portfolio
  24. 8.4.5 AlayaCare Recent Developments
  25. 8.5 Ivenix
  26. 8.5.1 Ivenix Company Information
  27. 8.5.2 Ivenix Business Overview
  28. 8.5.3 Ivenix Infusion Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ivenix Infusion Software Product Portfolio
  30. 8.5.5 Ivenix Recent Developments
  31. 8.6 CitusHealth
  32. 8.6.1 CitusHealth Company Information
  33. 8.6.2 CitusHealth Business Overview
  34. 8.6.3 CitusHealth Infusion Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CitusHealth Infusion Software Product Portfolio
  36. 8.6.5 CitusHealth Recent Developments
  37. 8.7 EpiSoft
  38. 8.7.1 EpiSoft Company Information
  39. 8.7.2 EpiSoft Business Overview
  40. 8.7.3 EpiSoft Infusion Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EpiSoft Infusion Software Product Portfolio
  42. 8.7.5 EpiSoft Recent Developments
  43. 8.8 Eitan Medical
  44. 8.8.1 Eitan Medical Company Information
  45. 8.8.2 Eitan Medical Business Overview
  46. 8.8.3 Eitan Medical Infusion Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eitan Medical Infusion Software Product Portfolio
  48. 8.8.5 Eitan Medical Recent Developments
  49. 8.9 ICU Medical
  50. 8.9.1 ICU Medical Company Information
  51. 8.9.2 ICU Medical Business Overview
  52. 8.9.3 ICU Medical Infusion Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ICU Medical Infusion Software Product Portfolio
  54. 8.9.5 ICU Medical Recent Developments
  55. 8.10 Weinfuse
  56. 8.10.1 Weinfuse Company Information
  57. 8.10.2 Weinfuse Business Overview
  58. 8.10.3 Weinfuse Infusion Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Weinfuse Infusion Software Product Portfolio
  60. 8.10.5 Weinfuse Recent Developments
  61. 8.11 Universal Software Solutions
  62. 8.11.1 Universal Software Solutions Company Information
  63. 8.11.2 Universal Software Solutions Business Overview
  64. 8.11.3 Universal Software Solutions Infusion Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Universal Software Solutions Infusion Software Product Portfolio
  66. 8.11.5 Universal Software Solutions Recent Developments
  67. 8.12 WellSky
  68. 8.12.1 WellSky Company Information
  69. 8.12.2 WellSky Business Overview
  70. 8.12.3 WellSky Infusion Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 WellSky Infusion Software Product Portfolio
  72. 8.12.5 WellSky Recent Developments
  73. 8.13 DoseMeRx
  74. 8.13.1 DoseMeRx Company Information
  75. 8.13.2 DoseMeRx Business Overview
  76. 8.13.3 DoseMeRx Infusion Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DoseMeRx Infusion Software Product Portfolio
  78. 8.13.5 DoseMeRx Recent Developments
  79. 8.14 MarketBox
  80. 8.14.1 MarketBox Company Information
  81. 8.14.2 MarketBox Business Overview
  82. 8.14.3 MarketBox Infusion Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MarketBox Infusion Software Product Portfolio
  84. 8.14.5 MarketBox Recent Developments
  85. 8.15 Daycenta
  86. 8.15.1 Daycenta Company Information
  87. 8.15.2 Daycenta Business Overview
  88. 8.15.3 Daycenta Infusion Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Daycenta Infusion Software Product Portfolio
  90. 8.15.5 Daycenta Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research